Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration
Noelle C. Anastasio, Dennis J. Sholler, Robert G. Fox, et al.
Neuropharmacology (2020) Vol. 168, pp. 108009-108009
Open Access | Times Cited: 25

Showing 25 citing articles:

Covid-19 interface with drug misuse and substance use disorders
Irma E. Cisneros, Kathryn A. Cunningham
Neuropharmacology (2021) Vol. 198, pp. 108766-108766
Open Access | Times Cited: 25
The psychedelic (−)-2,5-dimethoxy-4-iodoamphetamine [(−)-DOI] demonstrates efficacy in reducing cocaine reward and motivation in male rats
Leah M. Salinsky, Christina R. Merritt, Erik J. Garcia, et al.
Psychopharmacology (2025)
Open Access
Novel therapeutics in development for the treatment of stimulant-use disorder
Erica J. Young, László Radnai, В. А. Приходько, et al.
Current Opinion in Neurobiology (2024) Vol. 87, pp. 102898-102898
Open Access | Times Cited: 3
Chronic Cocaine Use and Parkinson’s Disease: An Interpretative Model
Manuel Glauco Carbone, Icro Maremmani
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 8, pp. 1105-1105
Open Access | Times Cited: 3
Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder
S. Stevens Negus, Matthew L. Banks
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1967-1973
Open Access | Times Cited: 23
Converging vulnerability factors for compulsive food and drug use
Katherine M. Serafine, Laura E. O’Dell, Eric P. Zorrilla
Neuropharmacology (2021) Vol. 196, pp. 108556-108556
Open Access | Times Cited: 19
Confronting the challenge of failed translation in medications development for substance use disorders
S. Stevens Negus, Matthew L. Banks
Pharmacology Biochemistry and Behavior (2021) Vol. 210, pp. 173264-173264
Open Access | Times Cited: 18
Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice
Salvador Sierra, Karan H. Muchhala, Donald K. Jessup, et al.
Neuropharmacology (2022) Vol. 209, pp. 108988-108988
Open Access | Times Cited: 13
The 5‐HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment‐seeking individuals
Erin J. Campbell, Yvonne Bonomo, Adam Pastor, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 18
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Gabriele Floris, Konrad Dabrowski, Mary Tresa Zanda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Gabriele Floris, Konrad Dabrowski, Mary Tresa Zanda, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 2
Serotonin research: Crossing scales and boundaries
Giuseppe Di Giovanni, Philippe De Deurwaerdère
Neuropharmacology (2020) Vol. 181, pp. 108340-108340
Open Access | Times Cited: 15
5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers
Caroline A. Arout, Ziva D. Cooper, Stephanie Collins Reed, et al.
Addiction Biology (2021) Vol. 26, Iss. 4
Open Access | Times Cited: 13
3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder
Michelle R. Doyle, Lindsey N. Peng, Jianjing Cao, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 384, Iss. 3, pp. 353-362
Open Access | Times Cited: 4
Lorcaserin: Worthy of Further Insights? Results from Recent Research
Marianna Mazza, Georgios D. Kotzalidis, Giuseppe Marano, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 278-283
Closed Access | Times Cited: 4
Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice
Bing Li, Junyu Jiang, Li Zhou, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 7
Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice.
Belle Buzzi, Shakir D. AlSharari, D. Matthew Walentiny, et al.
Behavioural Brain Research (2024) Vol. 467, pp. 115019-115019
Closed Access | Times Cited: 1
5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence
Guy A. Higgins, Edward M. Sellers
Progress in brain research (2021), pp. 229-263
Closed Access | Times Cited: 8
Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders
Ken W. Grasing, Kim Burnell, Alok De
Behavioural Pharmacology (2022) Vol. 33, Iss. 4, pp. 238-248
Open Access | Times Cited: 4
Effects of pimavanserin and lorcaserin on alcohol self-administration and reinstatement in male and female rats
Paul Fletcher, Zhaoxia Li, Ji X, et al.
Neuropharmacology (2022) Vol. 215, pp. 109150-109150
Closed Access | Times Cited: 4
Heightened cocaine-seeking in male rats associates with a distinct transcriptomic profile in the medial prefrontal cortex
Christina R. Merritt, Ashley Smith, Kamil Khanipov, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Role of neuropeptide neuromedin U in the nucleus accumbens shell in cocaine self-administration in male rats
James M. Kasper, Ashley Smith, S. Miller, et al.
Neuropsychopharmacology (2021) Vol. 47, Iss. 11, pp. 1875-1882
Open Access | Times Cited: 5
Novel Pharmacological Agents for the Treatment of Cocaine Use Disorder
Hasti Hadizadeh, José M. Flores, Eric J. Nunes, et al.
Current Behavioral Neuroscience Reports (2022) Vol. 9, Iss. 1, pp. 27-46
Closed Access | Times Cited: 3
Medial prefrontal cortical neurotransmitters reactive to relapse-promoting and relapse-suppressing cues in rats trained to self-administer cocaine or alcohol
Hermina Nedelescu, Cristina Miliano, Grant E. Wagner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
THE SEROTONIN 5-HT2ARECEPTOR AS AN EVOLVING NEUROTHERAPEUTIC TARGET
Andrew A. Bolinger, Noelle C. Anastasio, Kathryn A. Cunningham, et al.
Medicinal chemistry reviews (2023), pp. 53-81
Closed Access
Page 1

Scroll to top